News

GSK Rebranded Flovent Asthma Inhaler For Children To Avoid $367 Million Medicaid Rebate, Senator Hassan Accuses
U.S. Senator Maggie Hassan (D-NH) is intensifying her scrutiny of GSK Plc (NYSE:GSK) over the company's decision to pull its ...
STAT4d
Senator launches investigation into GSK’s asthma inhaler maneuvers
Amid ongoing controversy, Sen. Maggie Hassan (D-N.H.) is investigating GSK for replacing a popular asthma inhaler with a so-called authorized generic at a much higher price in order to avoid paying ...